The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Colluli SOP Project Update

21 May 2020 07:00

RNS Number : 5979N
Danakali Limited
21 May 2020
 

Announcement

Thursday, 21 May 2020

 

Colluli SOP Project Update

EPCM Phase 2 - FEED and Schedule update near completion.

 

- EPCM Phase 2 now in final stage, on budget, with completion in June 2020

- All contractor and vendor tender packages now returned allowing the evaluation stage to be completed

- Additional optimisation opportunities defined as part of the EPCM Phase 2 deliverables

Danakali Limited (ASX: DNK, LSE: DNK, Danakali, or the Company) is pleased to provide this project update of the Colluli Potash Project (Colluli or the Project), located in Eritrea, East Africa. The Project is 100% owned by the Colluli Mining Share Company (CMSC), a 50:50 joint venture between Danakali and the Eritrean National Mining Corporation (ENAMCO).

 

Even in light of COVID-19 restrictions, all EPCM Phase 2 workflows continued and all vendor and contractor packages have now been received in complete form. The receipt of these bids allows DRA Global (DRA) to finalise the tender evaluation process to provide a technically compliant and commercially favourable estimate.

 

Three key objectives set for the EPCM Phase 2 are:

- Update of the FEED Capital Estimate;

- Revision of the FEED Project Schedule; and

- Identification of key test work required to ensure full preparedness for EPCM Phase 3.

 

Completion of the identified test work items provides key data necessary to finalise process plant design development and will allow advancement into EPCM Phase 3 with clear direction.

 

A number of optimisation opportunities to improve project design will be presented at the end of EPCM Phase 2.

 

Announcement authorised for release by the Chief Executive Officer of Danakali.

 

For more information, please contact:

 

Danakali

 

Niels Wage

Chief Executive Officer

+61 8 6189 8635

Mark Riseley

Corporate Development Manager

+61 8 6189 8635

Corporate Broker - Numis Securities

UK IR/PR - Instinctif Partners

John Prior / James Black / Paul Gillam

+44 (0)20 7260 1000

Mark Garraway / Dinara Shikhametova / Sarah Hourahane

danakali@instinctif.com

+44 (0)207 457 2020

 

Visit the Company's website: www.danakali.com

Follow Danakali on LinkedIn: www.linkedin.com/company/danakali-limited

Subscribe to Danakali on YouTube: www.youtube.com/channel/UChGKN4-M4lOvPKxs9b-IJvw

About Danakali

 

Danakali Limited (ASX: DNK, LSE: DNK) (Danakali, or the Company) is an ASX- and LSE-listed potash company focused on the development of the Colluli Sulphate of Potash Project (Colluli or the Project). The Project is 100% owned by the Colluli Mining Share Company (CMSC), a 50:50 joint venture between Danakali and the Eritrean National Mining Corporation (ENAMCO).

 

The Project is located in the Danakil Depression region of Eritrea, East Africa, and is ~75km from the Red Sea coast, making it one of the most accessible potash deposits globally. Mineralisation within the Colluli resource commences at just 16m, making it the world's shallowest known potash deposit. The resource is amenable to open cut mining, which allows higher overall resource recovery to be achieved, is generally safer than underground mining, and is highly advantageous for modular growth.

 

The Company has completed a Front End Engineering Design (FEED) for the production of potassium sulphate, otherwise known as Sulphate of Potash or SOP. SOP is a chloride free, specialty fertiliser which carries a substantial price premium relative to the more common potash type; potassium chloride (or MOP). Economic resources for production of SOP are geologically scarce. The unique composition of the Colluli resource favours low energy input, high potassium yield conversion to SOP using commercially proven technology. One of the key advantages of the resource is that the salts are present in solid form (in contrast with production of SOP from brines) which reduces infrastructure costs and substantially reduces the time required to achieve full production capacity.

 

The resource is favourably positioned to supply the world's fastest growing markets. A binding take-or-pay offtake agreement has been confirmed with EuroChem Trading GmbH (EuroChem) for up to 100% (minimum 87%) of Colluli Module I SOP production.

 

Development Finance Institutions, Africa Finance Corporation (AFC) and African Export Import Bank (Afreximbank), have obtained formal credit approval to provide CMSC with US$200M in senior debt finance. The credit documentation was executed in December 2019, allowing drawdown of CMSC senior debt on satisfaction of customary conditions precedent. This represents the majority of funding required for the development and construction of the Colluli. AFC has also executed a Subscription Agreement to make a US$50M strategic equity investment in Danakali. The receipt of the first tranche of US$21.5M (A$31.8M) allowed commencement of the development.

 

Project execution has commenced and SOP production is expected during 2022. The Company's vision is to bring Colluli into production using the principles of risk management, resource utilisation and modularity, using the starting module (Module I) as a growth platform to develop the resource to its full potential.

 

 

Disclaimer

 

The information in this document is published to inform you about Danakali and its activities. Danakali has endeavoured to ensure that the information enclosed is accurate at the time of release, and that it accurately reflects the Company's intentions. To the extent permitted by law, the Company accepts no responsibility or liability for any losses or damages of any kind arising out of the use of any information contained in this document. Recipients should make their own enquiries in relation to any investment decisions.

 

No representation or warranty, express or implied, is or will be made by or on behalf of the Company, and no responsibility or liability is or will be accepted by the Company or its affiliates, as to the accuracy, completeness or verification of the information set out in this announcement, and nothing contained in this announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future. The Company and each of its affiliates accordingly disclaims, to the fullest extent permitted by law, all and any liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement or any such statement.

 

The distribution of this announcement outside the United Kingdom may be restricted by law and therefore any persons outside the United Kingdom into whose possession this announcement comes should inform themselves about and observe any such restrictions in connection with the distribution of this announcement. Any failure to comply with such restrictions may constitute a violation of the securities laws of any jurisdiction outside the United Kingdom.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSEMSIFESSEII
Date   Source Headline
10th Sep 20217:00 amRNSIssue of unlisted option & PDMR/PCA notifications
1st Sep 20217:02 amRNSTotal Voting Rights and Capital
1st Sep 20217:01 amRNSHalf-year Report
1st Sep 20217:00 amRNSChange to Board of Directors
11th Aug 20217:00 amRNSProposed Cancellation of London Listing
6th Aug 20217:56 amRNSIssue of Shares and Unlisted Options
2nd Aug 20217:00 amRNSTotal Voting Rights and Capital
30th Jul 20217:00 amRNSAmended Constitution
30th Jul 20217:00 amRNSResult of AGM
29th Jul 20217:00 amRNSQuarterly Activities Report and Appendix 5B
5th Jul 20217:00 amRNSCompany Presentation and Video
1st Jul 202111:06 amRNSNotice of AGM
1st Jul 20217:00 amRNSTotal Voting Rights
25th Jun 20219:31 amRNSNotification of PDMR transaction
25th Jun 20217:26 amRNSProposed issue of unlisted options
17th Jun 20217:00 amRNSColluli Project Update
11th Jun 20217:17 amRNSReport on Payments to Governments
1st Jun 20217:00 amRNSTotal Voting Rights and Capital
27th May 20217:00 amRNSColluli Project Update
21st May 20217:52 amRNSAppendix 3Y
21st May 20217:48 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSColluli Project - RO Plant Manufacturing Underway
12th May 20217:01 amRNSA$20.3M Placement Endorses Danakali's SOP Project
12th May 20217:00 amRNSCorrection of Announcement - Issue of Shares
6th May 20219:12 amRNSIssue of shares
6th May 20217:00 amRNSNotification of PDMR and PCA transactions
30th Apr 20219:53 amRNSAnnual Report to Shareholders
30th Apr 20217:00 amRNSQuarterly Activities Report and Appendix 5B
29th Apr 20217:05 amRNSCompany Presentation
29th Apr 20217:00 amRNSA$20.3M Placement to Advance Colluli
27th Apr 20217:00 amRNSASX Trading Halt and Proposed Fundraise
19th Apr 202110:15 amRNSAdviser Appointment
13th Apr 20217:00 amRNSResignation of CFO
6th Apr 20217:00 amRNSCorrection to Corporate Presentation
6th Apr 20217:00 amRNSTotal Voting Rights and Capital
31st Mar 20217:26 amRNSRelease of 2020 Financial Report
26th Mar 20217:00 amRNSExecutive Chairman remuneration
24th Mar 20219:31 amRNSIssue of unlisted options
24th Mar 20219:29 amRNSProposed issue of unlisted options
22nd Mar 20217:34 amRNSCompany Presentation
10th Mar 20217:00 amRNSClean energy zero carbon SOP
2nd Mar 20218:36 amRNSTotal Voting Rights and Capital
26th Feb 20217:00 amRNSAppointment of Executive Chairman and restructure
23rd Feb 20219:13 amRNSResponse to ASX price and volume query
15th Feb 20219:01 amRNSIssue of shares & options, PDMR/PCA transactions
11th Feb 20217:00 amRNSCompany Presentation
1st Feb 20217:53 amRNSTotal Voting Rights
29th Jan 20217:54 amRNSIssue of unlisted options
29th Jan 20217:50 amRNSProposed issue of securities
28th Jan 20217:37 amRNSQuarterly Report and Appendix 5B

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.